pharmaceutical investing MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
pharmaceutical investing Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
pharmaceutical investing Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update
Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients
pharmaceutical investing Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
pharmaceutical investing Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
pharmaceutical investing Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress
cannabis investing Koios Beverage Corp. Announces Final Bulletin and Trading Date in Connection with Fundamental Change Transaction
medical device investing Medtronic Announces FDA Approval of Infuse Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants
pharmaceutical investing Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia
Blue Sky Uranium Acquires Key Subsurface Data for Corcovo Uranium Project, Mendoza Province, Argentina
Group Eleven Drills Best Hole Yet at Ballywire: 39.7m of 9.5% Zn+Pb, 131 g/t Ag and 0.27% Cu, incl. 5.6m of 16.6% Zn+Pb, 370 g/t Ag and 0.86% Cu
